Receives greenlight from the FDA for Phase 1/2a clinical trial of CNA3103On track to commence patient enrollment during the first half 2023 ADELAIDE, Australia , Jan. 23, 2023 (GLOBE NEWSWIRE) -- Carina Biotech…
HIGHLIGHTS Files its first IND application for a CAR-T cell therapy targeting a solid cancer. The IND application is directed at a first-in-human Phase 1/2a clinical trial in advanced colorectal cancer patientsColorectal cancer is the…